Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Acramel

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
International Journal of Cancer|February 24, 2026
Trabectedin in the treatment of soft tissue sarcoma: Real-world data on effectiveness, safety, and financial implications from a European comprehensive cancer centerJean-Stéphane Giraud, Sarah Watson, Alexandre Acramel, et al.
British Journal of Clinical Pharmacology|February 25, 2024
Advanced prescription of injectable anticancer drugs: Safety assessment in a European Comprehensive Cancer Centre using the risk matrix approachAlexandre Acramel, Sandy Blondeel-Gomes, Mathilde Dupré, et al.
Scientific Reports|January 24, 2023
Identification of a human estrogen receptor α tetrapeptidic fragment with dual antiproliferative and anti-nociceptive actionBaptiste Jouffre, Alexandre Acramel, Mathilde Belnou, et al.
Breast Cancer (Tokyo, Japan)|April 10, 2024
Sacituzumab govitecan in metastatic triple-negative breast cancer patients treated at Institut Curie Hospitals: efficacy, safety, and impact of brain metastasesAlexandre De Moura, Delphine Loirat, Sarah Vaillant, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
International Journal of Cancer|February 24, 2026
Trabectedin in the treatment of soft tissue sarcoma: Real-world data on effectiveness, safety, and financial implications from a European comprehensive cancer centerJean-Stéphane Giraud, Sarah Watson, Alexandre Acramel, et al.
British Journal of Clinical Pharmacology|February 25, 2024
Advanced prescription of injectable anticancer drugs: Safety assessment in a European Comprehensive Cancer Centre using the risk matrix approachAlexandre Acramel, Sandy Blondeel-Gomes, Mathilde Dupré, et al.
Scientific Reports|January 24, 2023
Identification of a human estrogen receptor α tetrapeptidic fragment with dual antiproliferative and anti-nociceptive actionBaptiste Jouffre, Alexandre Acramel, Mathilde Belnou, et al.
Breast Cancer (Tokyo, Japan)|April 10, 2024
Sacituzumab govitecan in metastatic triple-negative breast cancer patients treated at Institut Curie Hospitals: efficacy, safety, and impact of brain metastasesAlexandre De Moura, Delphine Loirat, Sarah Vaillant, et al.
Pageof 2